EEG Mapping and Low-Resolution Brain Electromagnetic Tomography (LORETA) in Diagnosis and Therapy of Psychiatric Disorders: Evidence for a Key-Lock Principle

Clinical EEG and Neuroscience

Volumn 36, Issue 2, 2005, Pages 108-115

  Saletu, Bernd ^a   Anderer, Peter ^a   Saletu Zyhlarz, Gerda M ^a   Pascual Marqui, Roberto D ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

EEG Mapping; EEG Tomography; Key Lock Principle; Low Resolution Brain Electromagnetic Tomography (LORETA); Mental Disorders; Psychotropic Drugs

Indexed keywords

ARTICLE; BRAIN; BRAIN MAPPING; CLASSIFICATION; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED DIAGNOSIS; COMPUTER INTERFACE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FACTUAL DATABASE; HUMAN; MEDICAL RECORD; METHODOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; TOMOGRAPHY; AGORAPHOBIA; ALCOHOLISM; ALZHEIMER DISEASE; BRAIN TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; GENERALIZED ANXIETY DISORDER; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MAJOR DEPRESSION; MENTAL DISEASE; MULTIINFARCT DEMENTIA; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SCHIZOPHRENIA; SENILE DEMENTIA;

BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DATABASES, FACTUAL; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROENCEPHALOGRAPHY; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; TOMOGRAPHY; USER-COMPUTER INTERFACE;

AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CITALOPRAM; CLOBAZAM; HALOPERIDOL; HYPNOTIC AGENT; IMIPRAMINE; LORAZEPAM; METHAMPHETAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PLACEBO; PSYCHOSTIMULANT AGENT; PYRITINOL; SOMNIUM; TRANQUILIZER;

EID: 23244442121     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940503600210     Document Type: Article

References (18)

1. Duffy FH Bartels PH Burchfiel JL Significance probability mapping: An aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 1981; 51: 455-462.
2. Itil TM Shapiro DM Eralp E Akmann A Itil KZ Garbizu C. A new brain function diagnostic unit, including the dynamic brain mapping of computer-analyzed EEG, evoked potentials and sleep (a new hardware/software system and its application in psychiatry and psychopharmacology). New Trends Exp Clin Psychiat 1985; 1: 107-177.
3. John ER Prichep LS Fridman J Easton P. Neurometrics: Computer-assisted differential diagnosis of brain dysfunctions, Science 1988; 239: 162-169.
4. Maurer K Dierks T. Atlas of Brain Mapping. Topographic Mapping of EEG and Evoked Potentials. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer-Verlag; 1991.
5. Saletu B Küfferle B Anderer P Grünberger J Steinberger K. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms: Comparative studies with remoxipride/haloperidol. Eur Neuropsychopharmacology 1990; 1: 27-36.
6. Saletu B Anderer P Paulus E Grünberger J Wicke L Neuhold A, et al. EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alzheimer Dis Assoc Disord 1991; 5(suppl 1): 57-75.
7. Saletu B Brandstätter N Metka M Stamenkovic M Anderer P Semlitsch HV, et al. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas 1996; 23(1): 91-105.
8. Herrmann WM Abt K Coppola R Etevenon ET Gerber G Fink M, et al. International Pharmaco-EEG Group (IPEG): Recommendations for EEG and evoked potential mapping. Neuropsychobiology 1989; 22: 170-176.
9. Anderer P Saletu B Kinsperger K Semlitsch H. Topographic brain mapping of EEG in neuropsychopharmacology. I. Methodological aspects. Meth Find Exp Clin Pharmacol 1987; 9(6): 371-384.
10. Anderer P Semlitsch HV Saletu B Barbanoj MJ Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Res 1992; 45: 79-93.
11. Saletu B. Pharmacodynamics and EEG. I. From single-lead pharmaco-EEG to EEG mapping. In: Saletu B, Krijzer F, Ferber G, Anderer P, (eds). Electrophysiological Brain Research in Preclinical and Clinical Pharmacology and Related Fields-An Update. Vienna: Facultas Universitätsverlag; 2000; 139-156.
12. Pascual-Marqui RD Michel CM Lehmann D. Low resolution electromagnetic tomography: A new method for localizing electrical activity in the brain. Int J Psychophysiol 1994; 18: 49-65.
13. Pascual-Marqui RD Lehmann D Koenig T Kochi K Merlo MCG Hell D Koukkou M. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naïve, first-episode, productive schizophrenia. Psychiatry Res Neuroimaging 1999; 90: 169-179.
14. Anderer P Saletu B Pascual-Marqui RD Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res, Neuroimag 2000; 100: 81-96.
15. Saletu B Anderer P Pascual-Marqui RD. Pharmacodynamics and EEG. II. From EEG-mapping to EEG-tomography. In: Saletu B, Krijzer F, Ferber G, Anderer P, (eds). Electrophysiological Brain Research in Preclinical and Clinical Pharmacology and Related Fields-An Update. Vienna: Facultas Universitätsverlag; 2000; 157-163.
16. Saletu B Anderer P Pascual-Marqui RD Low-resolution electromagnetic tomography (LORETA) in psychopharmacology. Eur Arch Psychiatry Clin Neurosci 2000; 250(suppl 1): 9.
17. Itil TM Saletu B Davis S. EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. Biol Psychiatry 1972; 5: 1-13.
18. Saletu B. Central measures in schizophrenia. In: Van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ, (eds). Handbook of Biological Psychiatry. Part II, Brain Mechanisms and Abnormal Behavior-Psychophysiology. New York, Basel: Marcel Dekker Inc.; 1980: 97-144.